Urine biomarkers of pulmonary tuberculosis.


Journal

Expert review of respiratory medicine
ISSN: 1747-6356
Titre abrégé: Expert Rev Respir Med
Pays: England
ID NLM: 101278196

Informations de publication

Date de publication:
06 2022
Historique:
pubmed: 16 6 2022
medline: 29 7 2022
entrez: 15 6 2022
Statut: ppublish

Résumé

Sputum-based tuberculosis diagnosis does not address the needs of certain categories of patients. Active development of a noninvasive urine-based diagnosis could provide an alternative approach. We reviewed publications covering more than 30 urine biomarkers proposed as significant for TB diagnosis. Analytical approaches were heterogeneous in design and methods; few studies on diagnostic outcome prediction described a formal specificity and sensitivity analysis. This review describes studies of non-sputum diagnostic approaches of pulmonary TB based on urine using specific TB biomarkers. The search was performed until December 2021, using terms [Tuberculosis] + [urine] + [biomarkers] in PubMed and Cochrane databases. Publications concerning LAM urine diagnostics were excluded as they have been described elsewhere. Microbiological culture of sputum is considered to be the 'gold standard' diagnostic for pulmonary TB but the methodology is slow due to the slow growth of the TB bacteria. Urine provides a large volume of sample. Investigators have evaluated urine for either TB pathogen biomarkers or host biomarkers with some success as the review demonstrates. Detection sensitivity remains a significant problem. In future, combination of host and pathogen biomarkers could increase the sensitivity and specificity of TB diagnosis.

Identifiants

pubmed: 35702997
doi: 10.1080/17476348.2022.2090341
doi:

Substances chimiques

Biomarkers 0
Lipopolysaccharides 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

615-621

Auteurs

Elena Khimova (E)

Department of Phthisiopulmonology, Northern State Medical University, Arkhangelsk, Russia.

Ximena Gonzalo (X)

Department of Infectious Diseases, Imperial College London, London, UK.

Yulia Popova (Y)

Department of Phthisiopulmonology, Northern State Medical University, Arkhangelsk, Russia.

Platon Eliseev (P)

Department of Phthisiopulmonology, Northern State Medical University, Arkhangelsk, Russia.

Maryandyshev Andrey (M)

Department of Phthisiopulmonology, Northern State Medical University, Arkhangelsk, Russia.

Vladyslav Nikolayevskyy (V)

Department of Infectious Diseases, Imperial College London, London, UK.

Agnieszka Broda (A)

Department of Infectious Diseases, Imperial College London, London, UK.

Francis Drobniewski (F)

Department of Infectious Diseases, Imperial College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH